Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Net Income towards Common Stockholders (2018 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Net Income towards Common Stockholders of -$21.7 million for Q3 2026, compared with $2.37 million a year earlier.

Analysis

Amneal Pharmaceuticals (AMRX) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Net Income towards Common Stockholders at Amneal Pharmaceuticals was $133.3 million; for FY2025, it was $72.06 million.

  • Annual Net Income towards Common Stockholders shows a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Net Income towards Common Stockholders was -$116.89 million in FY2024, -$83.99 million in FY2023, -$129.99 million in FY2022 and $10.62 million in FY2021 (-88.3%).
  • The Q3 2026 figure stands as the lowest quarterly Net Income towards Common Stockholders since Q4 2024.
  • According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $57.66 million (Q2 2026), $62.26 million (Q1 2026) and $35.08 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.12 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.24 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn -21.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -21.70 Mn
Jun 30, 2026 57.66 Mn
Mar 31, 2026 62.26 Mn
Dec 31, 2025 35.08 Mn
Sep 30, 2025 2.37 Mn
Jun 30, 2025 22.42 Mn
Mar 31, 2025 12.20 Mn
Dec 31, 2024 -31.08 Mn
Sep 30, 2024 -156,000.00
Jun 30, 2024 5.99 Mn
Mar 31, 2024 -91.64 Mn
Dec 31, 2023 -98.65 Mn
Sep 30, 2023 9.68 Mn
Jun 30, 2023 11.92 Mn
Mar 31, 2023 -6.94 Mn
Dec 31, 2022 -4.33 Mn
Sep 30, 2022 -2.69 Mn
Jun 30, 2022 -120.81 Mn
Mar 31, 2022 -2.16 Mn
Dec 31, 2021 -6.38 Mn
API Access

Amneal Pharmaceuticals Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AMRX&period=max&api_key=YOUR_API_KEY